-
When complaints of dizziness in elderly patients were evaluated in primary care offices, the most common cause was cardiovascular disease, combined with contributions from adverse drug reactions. This contradicts many previous studies done in tertiary care settings where vertigo or vestibular disease was found to be the most common cause.
-
Clinicians are increasingly presented with the tasks of addressing not only a burgeoning population of type 2 diabetics, but an equally voluminous group of prediabetics.
-
The ECG shown above was obtained from a 50-year-old woman with "skipped beats." Is there anything unusual about these ectopic beats and the effect that they have on the normal beats in this tracing? What happens at the onset of the last lead change (i.e., at the onset where we see leads V4,V5,V6)?
-
More than three-fourths of men have some degree of male pattern hair loss by age 70. The unwanted hair loss seen in male pattern hair loss is stimulated by dihydrotestosterone.
-
Replacing saturated fatty acids with carbohydrates with low glycemic index values is associated with a lower risk of myocardial infarction.
-
In a sample of patients from primary care practice, a single screening question accurately identified drug use.
-
Lorcaserin submitted for FDA review, FDA advisory panel votes against phentermine/topiramate, mixed vote on rosiglitazone, advisory panel votes to remove breast cancer indication from bevacizumab labeling, no increase in seizures found with DTaP vaccine, new REMS for quinine.
-
A new three-drug antihypertensive pill, combining an angiotensin II receptor antagonist (olmesartan [OLM]), a calcium channel blocker (amlodipine [AML]), and a thiazide diuretic (hydrochlorothiazide [HCTZ]), has been approved by the FDA. The new combination is marketed by Daiichi Sankyo as Tribenzor.
-
Vital exhaustion predicts long-term risk for adverse cardiac events in men and women, independent of established biomedical risk factors.
-
Of late, there has been a renaissance of interest in identification and management of hypogonadism in older men.